| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,674 | 14,686 | 13,965 | 12,972 | | Cost of Revenue | 9,798 | 9,557 | 9,180 | 9,128 | | | Gross Profit | 4,876 | 5,129 | 4,785 | 3,844 | | | Operating Expenses | | Research Development | 228 | 192 | 159 | 192 | | Selling General and Administrative | 4,647 | 4,945 | 5,180 | 4,638 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 467 | 465 | 462 | 466 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (466) | (473) | (1,016) | (1,452) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 40 | 6 | (10) | 341 | | Earnings Before Interest And Taxes | (426) | (467) | (1,026) | (1,111) | | Interest Expense |
-
| (1) | 3 | 7 | | Income Before Tax | (426) | (466) | (1,029) | (1,118) | | Income Tax Expense | 199 | 137 | 143 | (1,591) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (625) | (603) | (1,172) | 473 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (625) | (603) | (1,172) | 473 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($625) | ($603) | ($1,172) | $473 |
|
0.03% Nasdaq 
Income Statement
